WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011. [electronic resource]
- Biologicals : journal of the International Association of Biological Standardization Nov 2012
- 507-16 p. digital
Publication Type: Congress
1095-8320
10.1016/j.biologicals.2012.09.008 doi
Global Health Licensure Meningitis, Meningococcal--epidemiology Meningococcal Vaccines--standards Molecular Epidemiology Ontario World Health Organization